ebook img

Diabetes Research and Clinical Practice 1991: Vol 13 Index PDF

9 Pages·1991·1.9 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Diabetes Research and Clinical Practice 1991: Vol 13 Index

Diabetes Research and Clinical Practice, 13 (1991) 223-226 © 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50 Author Index to Volume 13 (1991) Ahrén, B., Pettersson, M., Uvnas-Moberg, K., Gutniak, M. Duner, E., see Bruttomesso, D., 15 and Efendic, S., Effects of cholecystokinin (CCK)-8, Durlach, V., see Grulet, H., 189 CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion Efendic, S., see Ahrén, B., 153 in man, 153 Eggstein, M., see Lingenfelser, Th., 29 Alberti, K.G.M.M., see Davis, S.N., 107 Fernando, D.J.S., see Kumar, S., 63 Andersson, P.-O., see Wikby, A., 53 Fongher, C., see Bruttomesso, D., 15 Aoki, Y., Yanagisawa, Y., Ohfusa, H., Kawa, S., Oguchi, H. Forrest, R.D., see Yudkin, J.S., 1 and Furuta, S., Elevation of serum CA 19-9 in parallel Fujimoto, W.Y., Leonetti, D.L., Bergstrom, R.W., Kinyoun, with HbA,, in a diabetic female with the Lewis(a + b — ) J.L., Stolov, W.C. and Wahl, P.W., Glucose intolerance blood group, 77 and diabetic complications among Japanese- American Asha Bai, P.V., Krishnaswami, C.V., Chellamariappan, M.., women, 119 Vijaya Kumar, G. and Subramaniam, J.R., Glycosuria Fukuda, M., see Cha, T., 181 and diabetes mellitus in children and adolescents in south Furuta, S., see Aoki, Y., 77 India, 131 Gliick, H., see Lingenfelser, Th., 29 Baba, S., see Yoshida, M., 147 Griffing, G., see Kimmerle, R., 69 Bergstrom, R.W., see Fujimoto, W.Y., 119 Gross, A., see Grulet, H., 189 Biolo, G., see Bruttomesso, D., 15 Grulet, H., Gross, A., Pasqual, C., Durlach, V. and Boulton, A.J.M., see Kumar, S., 63 Leutenegger, M., Remission of insulin requirement in late Briani, G., see Bruttomesso, D., 15 secondary failure to oral hypoglycemic agents (IRD): Brown, M.D., see Davis, S.N., 107 results at 24 months and analysis of predictive factors, Bruttomesso, D., Biolo, G., Inchiostro, S., Fongher, C., 189 Briani, G., Duner, E., Marescotti, M.C., Iori, E., Tiengo, Gutniak, M., see Ahrén, B., 153 A. and Tessari, P., No effects of high-fiber diets on metabolic control and insulin-sensitivity in type 1 Harano, Y., see Suzuki, M., 163 diabetic subjects, 15 Hidaka, H., see Suzuki, M., 163 Home, P.D., see Davis, S.N., 107 Cha, T., Tahara, Y., Ikegami, H., Fukuda, M., Yoneda, H., Hong, S.Y., see Cho, Y.W., 139 Yamato, E., Yamamoto, Y., Noma, Y., Shima, K. and Hozumi, T., see Yoshida, M., 147 Ogihara, T., Urinary C-peptide as an index of unstable Huh, K.B., see Cho, Y.W., 139 glycemic control in insulin- dependent diabetes mellitus Hoérnquist, J.O., see Wikby, A., 53 (IDDM), 181 Chellamariappan, M., see Asha Bai, P.V., 131 Ikegami, H., see Cha, T., 181 Cho, Y.W., Oh, D.Y., Kim, S.J., Hong, S.Y., Lee, H.C. and Inchiostro, S., see Bruttomesso, D., 15 Huh, K.B., Euglobulin fibrinolytic activity in NIDDM Iori, E., see Bruttomesso, D., 15 patients, 139 Ishida, Y., see Yoshida, M., 147 Cullen, D.R., see Tesfaye, S., 83 Isotani, H., see Majima, T., 207 Itakura, M., see Kunika, K., 37 Davis, S.N., Thompson, C.J., Brown, M.D., Home, P.D. and Iwama, N., see Lee, J.Y., 173 Alberti, K.G.M.M., A comparison of the pharmaco- kinetics and metabolic effects of human regular and NPH Jackson, C.A., see Yudkin, J.S., 1 insulin mixtures, 107 Jakober, B., see Lingenfelser, Th., 29 Doi, K., see Yoshida, M., 147 224 Kamada, T., see Lee, J.Y., 173 postpartum thyrotoxicosis: a case report, 207 Kamado, K., see Sasaki, A., 213 Marescotti, M.C., see Bruttomesso, D., 15 Kashigawi, A., see Suzuki, M., 163 McCall, A., see Kimmerle, R., 69 Katsumata, K., Okada, T., Miyao, M. and Katsumata, Y., Melby, J.C., see Kimmerle, R., 69 High incidence of sleep apnea syndrome in a male diabetic Mimoto, H., see Yoshida, M., 147 population, 45 Miyao, M., see Katsumata, K., 45 Katsumata, Y., see Katsumata, K., 45 Kawa, S., see Aoki, Y., 77 Nakano, T., see Suzuki, M., 163 Kawamori, R., see Lee, J.Y., 173 Nieuwenhuijzen Kruseman, A.C., see Wolffenbuttel, B.H.R., Kazumi, T., see Yoshida, M., 147 199 Kerp, L., see Petersen, K.-G., 23 Noma, Y., see Cha, T., 181 Khalaf, A., see Petersen, K.-G., 23 Khoja, S.M. and Salem, A.M., Regulation of 6-phospho- Ogihara, T., see Cha, T., 181 fructo-1-kinase in the placenta and small intestine of Oguchi, H., see Aoki, Y., 77 pregnant streptozotocin-induced diabetic rats, 85 Oh, D.Y., see Cho, Y.W., 139 Kim, S.J., see Cho, Y.W., 139 Ohfusa, H., see Aoki, Y., 77 Kimmerle, R., Griffing, G., McCall, A., Ruderman, N.B., Ohsawa, N., see Majima, T., 207 Stolz, E. and Melby, J.C., Could intranasal insulin be Okada, T., see Katsumata, K., 45 useful in the treatment of non-insulin-dependent diabetes Overkamp, D., see Lingenfelser, Th., 29 mellitus?, 69 Kinyoun, J.L., see Fujimoto, W.Y., 119 Papaccio, G., Prevention of low dose streptozotocin-induced Kitazawa, A., see Majima, T., 207 diabetes by acetyl- homocysteine-thiolactone, 95 Knols, A.J.F., see Wolffenbuttel, B.H.R., 199 Pasqual, C., see Grulet, H., 189 Knowles, E.A., see Kumar, S., 63 Petersen, K.-G., Khalaf, A. and Kerp, L., Lack of B,-adreno- Kojima, H., see Suzuki, M., 163 ceptor induced long-acting effect on glucose tolerance in Kosugi, K., see Suzuki, M., 163 type 2 diabetic patients, 23 Krishnaswami, C.V., see Asha Bai, P.V., 131 Pettersson, M., see Ahrén, B., 153 Kumar, S., Fernando, D.J.S., Veves, A., Knowles, E.A., Young, M.J. and Boulton, A.J.M., Semmes-Weinstein Raskin, P., see Sullivan, K., 103 monofilaments: a simple, effective and inexpensive Renn, W., see Lingenfelser, Th., 29 screening device for identifying diabetic patients at risk of Ruderman, N.B., see Kimmerle, R., 69 foot ulceration, 63 Kunika, K., Itakura, M. and Yamashita, K., Correction of Sakane, S., see Majima, T., 207 fructosamine value for serum albumin and globulin con- Salem, A.M., see Khoja, S.M., 85 centrations, 37 Sasaki, A., Kamado, K. and Uehara, M., A changing pattern of causes of death among diabetic patients during a Lee, H.C., see Cho, Y.W., 139 25-year period in the Osaka District, Japan, 213 Lee, J.Y., Iwama, N., Watarai, T., Yamamsaki, Y., Sasaki, E., see Majima, T., 207 Kawamori, R. and Kamada, T., Inhibitory effect of Sawa, J., see Yoshida, M., 147 methylguanidine on insulin binding to its receptor. Sels, J.-P.J.E., see Wolffenbuttel, B.H.R., 199 Mechanism underlying insulin resistance in uremia, 173 Shigeta, Y., see Suzuki, M., 163 Leonetti, D.L., see Fujimoto, W.Y., 119 Shima, K., see Cha, T., 181 Leutenegger, M., see Grulet, H., 189 Slits, W.L.H., see Wolffenbuttel, B.H.R., 199 Lingenfelser, Th., Overkamp, D., Renn, W., Gliick, H., Stolov, W.C., see Fujimoto, W.Y., 119 Maassen, M., Eggstein, M. and Jakober, B., Different Stoltz, E., see Kimmerle, R., 69 awareness of hypoglycaemia induced by human or puri- Subramanian, J.R., see Asha Bai, P.V., 131 fied pork insulin in type I diabetic patients, 29 Sullivan, K. and Raskin, P., Evaluation of a new automated affinity-chromatographic method for the measurement of Maassen, M., see Lingenfelser, Th., 29 glycated hemoglobin, 103 Majima, M., see Majima, T., 207 Suzuki, M., Kojima, H. Nakano, T., Kashiwagi, A., Hidaka, Majima, T., Takamatsu, J., Isotani, H., Majima, M., Sakane, H., Kosugi, K., Shigeta, Y. and Harano, Y., In vitro S., Yoshida, S., Sasaki, E., Taka, T., Kitazawa, A. and stimulation of glucose utilization by insulin in primary Ohsawa, N., Insulin-dependent diabetes mellitus in cultures of rat hepatocytes, 163 which glycemic control was improved during pregnancy but deteriorated after delivery with the occurrence of Tahara, Y., see Cha, T., 181 225 Taka, T., see Majima, T., 207 Wolffenbuttel, B.H.R., van Vliet, S., Knols, A.J.F., Slits, Takamatsu, J., see Majima, T., 207 W.L.H., Sels, J.-P.J.E. and Nieuwenhuijzen Kruseman, Tesfaye, S., Cullen, D.R., Wilson, R.M. and Woolley, P.D., A.C., Clinical characteristics and management of diabetic Diabetic ketoacidosis precipitated by genital herpes patients residing in a nursing home, 199 infection, 83 Woolley, P.D., see Tesfaye, S., 83 Tessari, P., see Bruttomesso, D., 15 Thompson, C.J., see Davis, S.N., 107 Yamamoto, Y., see Cha, T., 181 Tiengo, A., see Bruttomesso, D., 15 Yamasaki, Y., see Lee, J.Y., 173 Yamashita, K., see Kunika, K., 37 Uehara, M., see Sasaki, A., 213 Yamato, E., see Cha, T., 181 Uvnis-Moberg, see Ahrén, B., 153 Yanagisawa, Y., see Aoki, Y., 77 Yoneda, H., see Cha, T., 181 van Vliet, S., see Wolffenbuttel, B.H.R., 199 Yoshida, M., Sawa, J., Hozumi, T., Mimoto, H., Ishida, Y., Veves, A., see Kumar, S., 63 Kazumi, T., Doi, K. and Baba, S., Effects of long-term Vijaya Kumar, G., see Asha Bai, P.V., 131 high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic SD rats, 147 Wahl, P.W., see Fujimoto, W.Y., 119 Yoshida, S., see Majima, T., 207 Watarai, T., see Lee, J.Y., 173 Young, M.J., see Kumar, S., 63 Wikby, A., Hdérnquist, J.O. and Andersson, P.-O., Yudkin, J.S., Forrest, R.D. and Jackson, C.A., Misclassifi- Background, quality of life and metabolic control in cation of diabetic subjects may account for the increased patients with insulin-dependent diabetes mellitus, 53 vascular risk of impaired glucose tolerance: the Islington Wilson, R.M., see Tesfaye, S., 83 Diabetes Survey, 1 sachs Diabetes Research and Clinical Practice, 13 (1991) 227-230 © 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50 Key Word Index to Volume 13 (1991) B-Adrenergic effect Peripheral vascular disease; Hypertension; Glucose tol- — Type 2 diabetes mellitus; Glucose tolerance; Hyper- erance test, 1 glycemia; Hyperinsulinemia, 23 Coronary heart disease Albumin — Complication; Diabetes; Epidemiology; Hypertension; — Fructosamine; Globulin; Glycation; Diabetes mellitus, Impaired glucose tolerance; Japanese-American; Periph- 37 eral vascular disease; Women, 119 Atheroma formation — High-fiber diet; Macrovascular change, 147 Death certificate Autonomic and neuroglycopenic symptoms — Diabetes mellitus; Causes of death; Multiple coding — Diabetes mellitus; IDDM; Hypoglycaemia; Unaware- system; Long-term observation, 213 ness; Hormonal counterregulation, 29 Diabetes - Phosphofructokinase; Insulin; Pregnant; Placenta; Biothesiometer Small intestine, 85 — Foot ulcers; Neuropathy; Monofilaments, 63 Diabetes Blood glucose control — Coronary heart disease; Complication; Epidemiology; — Diabetes mellitus; Nursing home; Stroke; Hyper- Hypertension; Impaired glucose tolerance; Japanese- tension; Cardiovascular disease; Lipids, 199 American; Peripheral vascular disease; Women, 119 Body type Diabetes mellitus -— Sleep apnea syndrome; Diabetes mellitus; Hyper- — High-fiber diet; Metabolic control; Insulin-sensitivity, tension, 45 15 Brittle diabetes Diabetes mellitus — Urinary C-peptide excretion; Residual f-cell function; -IDDM; Hypoglycaemia; Unawareness; Autonomic Glycemic stability, 181 and neuroglycopenic symptoms; Hormonal counterregu- lation, 29 CA 19-9 Diabetes mellitus — Sex; Lewis blood group; Hyperglycemia, 77 - Fructosamine; Albumin; Globulin; Glycation, 37 Cardiovascular disease Diabetes mellitus — Diabetes mellitus; Nursing home; Stroke; Hyper- — Sleep apnea syndrome; Hypertension; Body type, 45 tension; Blood glucose control; Lipids, 199 Diabetes mellitus Causes of death — Glycosylated hemoglobin, 103 — Diabetes mellitus; Death certificate; Multiple coding Diabetes mellitus system; Long-term observation, 213 — Nursing home; Stroke; Hypertension; Cardiovascular Cholecystokinin disease; Blood glucose control; Lipids, 199 — GIP; Insulin secretion; Glucagon secretion; Somato- Diabetes mellitus statin secretion; Pancreatic polypeptide secretion; In — Death certificate; Causes of death; Multiple coding sys- vivo; Man, 153 tem; Long-term observation, 213 Citiolone Diabetic retinopathy — Type 1 diabetes; Stretozotocin; Syperoxide dismutase, — Euglobulin fibrinolytic activity, 139 95 Complication Enzyme activation —Coronary heart disease; Diabetes; Epidemiology; — Hepatocyte; Glucose utilization; Insulin action; Hypertension; Impaired glucose tolerance; Japanese- Enzyme induction, 163 American; Peripheral vascular disease; Women, 119 Enzyme induction Coronary heart disease — Hepatocyte; Glucose utilization; Insulin action; —Impaired glucose tolerance; Macrovascular disease; Enzyme activation, 163 228 Epidemiology — Diabetes mellitus; IDDM; Hypoglycaemia; Unaware- -Coronary heart disease; Complication; Diabetes; ness; Autonomic and neuroglycopenic symptoms, 29 Hypertension; Impaired glucose tolerance; Japanese- Hyperglycemia American; Peripheral vascular disease; Women, 119 — Type 2 diabetes mellitus; B,-adrenergic effect; Glucose Euglobulin fibrinolytic activity tolerance; Hyperinsulinemia, 23 — Diabetic retinopathy, 139 Hyperglycemia -—CA 19-9; Sex; Lewis blood group, 77 Foot ulcers Hyperinsulinemia — Neuropathy; Monofilaments; Biothesiometer, 63 — Type 2 diabetes mellitus; B,-adrenergic effect; Glucose Fructosamine tolerance; Hyperglycemia, 23 -— Albumin; Globulin; Glycation; Diabetes mellitus, 37 Hypertension —Impaired glucose tolerance; Macrovascular disease; GIP Peripheral vascular disease; Coronary heart disease; — Cholecystokinin; Insulin secretion; Glucagon secre- Glucose tolerance test, 1 tion; Somatostatin secretion; Pancreatic polypeptide Hypertension secretion; In vivo; Man, 153 — Sleep apnea syndrome; Diabetes mellitus; Body type, Genital herpes 45 - Ketoacidosis, 83 Hypertension Globulin -— Coronary heart disease; Complication; Diabetes; Epi- — Fructosamine; Albumin; Glycation; Diabetes mellitus, demiology; Impaired glucose tolerance; Japanese- 37 American; Peripheral vascular disease; Women, 119 Glucagon secretion Hypertension — Cholecystokinin; GIP; Insulin secretion; Somatostatin — Diabetes mellitus; Nursing home; Stroke; Cardio- secretion; Pancreatic polypeptide secretion; In vivo; vascular disease; Blood glucose control; Lipids, 199 Man, 153 Hypoglycaemia Glucose tolerance test — Diabetes mellitus; IDDM; Unawareness; Autonomic —Impaired glucose tolerance; Macrovascular disease; and neuroglycopenic symptoms; Hormonal counterregu- Peripheral vascular disease; Hypertension; Coronary lation, 29 heart disease, 1 Glucose tolerance IDDM — Type 2 diabetes mellitus; B,-adrenergic effect; Hyper- -— Diabetes mellitus; Hypoglycaemia; Unawareness; glycemia; Hyperinsulinemia, 23 Autonomic and neuroglycopenic symptoms; Hormonal Glucose utilization counterregulation, 29 -— Hepatocyte; Insulin action; Enzyme activation; En- IDDM zyme induction, 163 — Glycosuria; NIDDY (MODY); Incidence, 131 Glycation IDDM - Fructosamine; Albumin; Globulin; Diabetes mellitus, — Slowly progressive IDDM; Pregnancy; Postpartum 37 thyroiditis, 207 Glycemic stability Impaired glucose tolerance — Urinary C-peptide excretion; Brittle diabetes; Residual — Macrovascular disease; Peripheral vascular disease; B-cell function, 181 Hypertension; Coronary heart disease; Glucose toler- Glycosuria ance test, 1 - IDDM; NIDDY (MODY); Incidence, 131 Impaired glucose tolerance Glycosylated hemoglobin — Coronary heart disease; Complication; Diabetes; Epi- — Diabetes mellitus, 103 demiology; Hypertension; Japanese-American; Periph- eral vascular disease; Women, 119 Hepatocyte In vivo — Glucose utilization; Insulin action; Enzyme activation; — Cholecystokinin; GIP; Insulin secretion; Glucagon Enzyme induction, 163 secretion; Somatostatin secretion; Pancreatic polypep- High-fiber diet tide secretion; Man, 153 — Metabolic control; Insulin-sensitivity; Diabetes mel- Incidence litus, 15 — Glycosuria; IDDM; NIDDY (MODY), 131 High-fiber diet Insulin — Macrovascular change; Atheroma formation, 147 — Nasal drug therapy; NIDDM, 69 Hormonal counterregulation Insulin 229 - Phosphofructokinase; Diabetes; Pregnant; Placenta; secretion; Somatostatin secretion; Pancreatic polypep- Small intestine, 85 tide secretion; In vivo, 153 Insulin action Metabolic control — Hepatocyte; Glucose utilization; Enzyme activation; — High-fiber diet; Insulin-sensitivity; Diabetes mellitus, Enzyme induction, 163 15 Insulin pump Methylguanidine — Type 2 diabetes; Insulin-requiring diabetes; Remission; - Insulin receptor; Insulin resistance; Uremia, 173 Predictive factors, 189 Monofilaments Insulin receptor — Foot ulcers; Neuropathy; Biothesiometer, 63 — Insulin resistance; Uremia; Methylguanidine, 173 Multiple coding system Insulin resistance — Diabetes mellitus; Death certificate; Causes of death; — Insulin receptor; Uremia; Methylguanidine, 173 Long-term observation, 213 Insulin secretion — Cholecystokinin; GIP; Glucagon secretion; Somato- NIDDM statin secretion; Pancreatic polypeptide secretion; In — Nasal drug therapy; Insulin, 69 vivo; Man, 153 NIDDY (MODY) Insulin therapy — Glycosuria; IDDM; Incidence, 131 — Intermediary metabolism, 107 Nasal drug therapy Insulin-dependent diabetes mellitus - Insulin; NIDDM, 69 — Social background; Quality of life and metabolic con- Neuropathy trol, 53 - Foot ulcers; Monofilaments; Biothesiometer, 63 Insulin-requiring diabetes Nursing home — Type 2 diabetes; Remission; Insulin pump; Predictive — Diabetes mellitus; Stroke; Hypertension; Cardiovascu- factors, 189 lar disease; Blood glucose control; Lipids, 199 Insulin-sensitivity — High-fiber diet; Metabolic control; Diabetes mellitus, Pancreatic polypeptide secretion 15 — Cholecystokinin; GIP; Insulin secretion; Glucagon Intermediary metabolism secretion; Somatostatin secretion; In vivo; Man, 153 — Insulin therapy, 107 Peripheral vascular disease -—Impaired glucose tolerance; Macrovascular disease; Japanese-American Hypertension; Coronary heart disease; Glucose toler- — Coronary heart disease; Complication; Diabetes; Epi- ance test, 1 demiology; Hypertension; Impaired glucose tolerance; Peripheral vascular disease Peripheral vascular disease; Women, 119 — Coronary heart disease; Complication; Diabetes; Epi- Ketoacidosis demiology; Hypertension; Impaired glucose tolerance; — Genital herpes, 83 Japanese-American; Women, 119 Phosphofructokinase Lewis blood group — Diabetes; Insulin; Pregnant; Placenta; Small intestine, -CA 19-9; Sex; Hyperglycemia, 77 85 Lipids Placenta - Diabetes mellitus; Nursing home; Stroke; Hyper- — Phosphofructokinase; Diabetes; Insulin; Pregnant; tension; Cardiovascular disease; Blood glucose control, Small intestine, 85 199 Postpartum thyroiditis Long-term observation - IDDM; Slowly progressive IDDM; Pregnancy, 207 — Diabetes mellitus; Death certificate; Causes of death; Predictive factors Multiple coding system, 213 — Type 2 diabetes; Insulin-requiring diabetes; Remission; Insulin pump, 189 Macrovascular disease Pregnancy — Impaired glucose tolerance; Peripheral vascular dis- - IDDM; Slowly progressive IDDM; Postpartum thy- ease; Hypertension; Coronary heart disease; Glucose roiditis, 207 tolerance test, 1 Pregnant Macrovascular change - Phosphofructokinase; Diabetes; Insulin; Placenta; — High-fiber diet; Atheroma formation, 147 Small intestine, 85 Man — Cholecystokinin; GIP; Insulin secretion; Glucagon Quality of life and metabolic control 230 — Insulin-dependent diabetes mellitus; Social — Diabetes mellitus; Nursing home; Hypertension; background, 53 Cardiovascular disease; Blood glucose control; Lipids, 199 Remission Superoxide dismutase - Type 2 diabetes; Insulin-requiring diabetes; Insulin — Type | diabetes; Streptozotocin; Citiolone, 95 pump; Predictive factors, 189 Residual f-cell function Type 1 diabetes — Urinary C-peptide excretion; Brittle diabetes; Glycemic — Streptozotocin; Citiolone; Superoxide dismutase, 95 stability, 181 Type 2 diabetes mellitus — fB,-adrenergic effect; Glucose tolerance; Hyper- Sex glycemia; Hyperinsulinemia, 23 -CA 19-9; Lewis blood group; Hyperglycemia, 77 Type 2 diabetes Sleep apnea syndrome — Insulin-requiring diabetes; Remission; Insulin pump; — Diabetes mellitus; Hypertension; Body type, 45 Predictive factors, 189 Slowly progressive IDDM - IDDM; Pregnancy; Postpartum thyroiditis, 207 Unawareness Small intestine — Diabetes mellitus; IDDM; Hypoglycaemia; Autonomic — Phosphofructokinase; Diabetes; Insulin; Pregnant; and neuroglycopenic symptoms; Hormonal counterregu- Placenta, 85 lation, 29 Social background Uremia — Insulin-dependent diabetes mellitus; Quality of life and — Insulin receptor; Insulin resistance; Methylguanidine, metabolic control, 53 173 Somatostatin secretion Urinary C-peptide excretion — Cholecystokinin; GIP; Insulin secretion; Glucagon - Brittle diabetes; Residual f-cell function; Glycemic secretion; Pancreatic polypeptide secretion; In vivo; stability, 181 Man, 53 Streptozotocin Women -— Type | diabetes; Citiolone; Superoxide dismutase, 95 - Coronary heart disease; Complication; Diabetes; Epi- Stroke demiology; Hypertension; Impaired glucose tolerance; Japanese-American; Peripheral vascular disease, 119

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.